Werewolf Therapeutics (HOWL) Other Gross PP&E Adjustments (2021 - 2025)

Werewolf Therapeutics (HOWL) has disclosed Other Gross PP&E Adjustments for 5 consecutive years, with -$5.4 million as the latest value for Q3 2025.

  • On a quarterly basis, Other Gross PP&E Adjustments rose 12.24% to -$5.4 million in Q3 2025 year-over-year; TTM through Sep 2025 was -$5.4 million, a 12.24% increase, with the full-year FY2024 number at $3.4 million, up 52.5% from a year prior.
  • Other Gross PP&E Adjustments was -$5.4 million for Q3 2025 at Werewolf Therapeutics, up from -$5.6 million in the prior quarter.
  • In the past five years, Other Gross PP&E Adjustments ranged from a high of $3.4 million in Q4 2024 to a low of -$11.2 million in Q1 2022.
  • A 5-year average of -$4.2 million and a median of -$5.6 million in 2025 define the central range for Other Gross PP&E Adjustments.
  • Biggest YoY gain for Other Gross PP&E Adjustments was 359.42% in 2023; the steepest drop was 1326.46% in 2023.
  • Werewolf Therapeutics' Other Gross PP&E Adjustments stood at -$10.6 million in 2021, then surged by 104.55% to $483000.0 in 2022, then soared by 359.42% to $2.2 million in 2023, then surged by 52.5% to $3.4 million in 2024, then plummeted by 260.22% to -$5.4 million in 2025.
  • Per Business Quant, the three most recent readings for HOWL's Other Gross PP&E Adjustments are -$5.4 million (Q3 2025), -$5.6 million (Q2 2025), and -$5.8 million (Q1 2025).